Open Market Insiders Trades - Sells only
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
CORT
|
Joseph Douglas Lyon |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 36.34% |
$334,600
$66.92 p/Share
|
Feb 03
2025 |
|
WLFC
|
Austin Chandler Willis
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 3,450 Reduced 2.09% |
$661,675
$191.79 p/Share
|
Feb 03
2025 |
|
CHWY
|
Satish Mehta
Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 11,755 Reduced 2.63% |
$448,335
$38.14 p/Share
|
Feb 03
2025 |
|
PPL
|
David J Bonenberger
SVP & COO-Utilities of PPL Sub |
SELL
Open market or private sale
|
Direct | 17,178 Reduced 27.44% |
$573,401
$33.38 p/Share
|
Feb 03
2025 |
|
INTA
|
Scott Fitzgerald
Chief Marketing Officer |
SELL
Open market or private sale
|
Direct | 3,000 Reduced 7.65% |
$209,670
$69.89 p/Share
|
Feb 03
2025 |
|
CORT
|
Sean Maduck |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 18.99% |
$1,338,400
$66.92 p/Share
|
Feb 03
2025 |
|
CART
|
Fidji Simo
PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct | 20,750 Reduced 1.17% |
$979,607
$47.21 p/Share
|
Feb 03
2025 |
|
CHWY
|
David Reeder
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 53,834 Reduced 10.29% |
$2,053,228
$38.14 p/Share
|
Feb 03
2025 |
|
HWBK
|
Jonathan Holtaway
Director |
SELL
Open market or private sale
|
Indirect | 1,761 Reduced 0.0% |
$57,725
$32.78 p/Share
|
Feb 03
2025 |
|
OSIS
|
Deepak Chopra
EXECUTIVE CHAIRMAN |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 4.94% |
$3,871,000
$193.55 p/Share
|
Feb 03
2025 |
|
HMN
|
Marita Zuraitis
President & CEO |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 1.34% |
$149,480
$37.37 p/Share
|
Feb 03
2025 |
|
HQL
|
Saba Capital Management, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 1,846 Reduced 0.0% |
$25,899
$14.03 p/Share
|
Feb 03
2025 |
|
VZ
|
Kyle Malady
EVP and Group CEO-VZ Business |
SELL
Open market or private sale
|
Direct | 8,000 Reduced 54.83% |
$319,040
$39.88 p/Share
|
Feb 03
2025 |
|
NXJ
|
Saba Capital Management, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 8,836 Reduced 0.0% |
$107,180
$12.13 p/Share
|
Feb 03
2025 |
|
BCAT
|
Saba Capital Management, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 35,272 Reduced 0.0% |
$545,305
$15.46 p/Share
|
Feb 03
2025 |
|
MPA
|
Saba Capital Management, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 8,648 Reduced 0.0% |
$102,651
$11.87 p/Share
|
Feb 03
2025 |
|
HURN
|
John Mccartney
Director |
SELL
Open market or private sale
|
Direct | 500 Reduced 0.88% |
$62,575
$125.15 p/Share
|
Feb 03
2025 |
|
BFZ
|
Saba Capital Management, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 7,951 Reduced 0.0% |
$89,766
$11.29 p/Share
|
Feb 03
2025 |
|
HURN
|
H Eugene Lockhart
Director |
SELL
Open market or private sale
|
Direct | 1,042 Reduced 4.05% |
$130,406
$125.15 p/Share
|
Feb 03
2025 |
|
AKRO
|
Jonathan Young
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 3.83% |
$538,100
$53.81 p/Share
|
Feb 03
2025 |
|
PKBK
|
Jeffrey H Kripitz
Director |
SELL
Open market or private sale
|
Direct | 59 Reduced 0.09% |
$1,194
$20.25 p/Share
|
Feb 03
2025 |
|
NTRA
|
Michael Burkes Brophy
CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct | 43,502 Reduced 38.12% |
$7,693,763
$176.86 p/Share
|
Feb 03
2025 |
|
EVGO
|
Dennis G Kish
President |
SELL
Open market or private sale
|
Direct | 44,184 Reduced 31.52% |
$150,667
$3.41 p/Share
|
Feb 03
2025 |
|
TVTX
|
Sandra Calvin
SVP, CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct | 3,348 Reduced 5.0% |
$67,361
$20.12 p/Share
|
Feb 03
2025 |
|
TVTX
|
Christopher R. Cline
CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct | 5,192 Reduced 5.45% |
$104,463
$20.12 p/Share
|
Feb 03
2025 |
|
TVTX
|
Peter Heerma
CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct | 5,166 Reduced 4.04% |
$103,939
$20.12 p/Share
|
Feb 03
2025 |
|
TVTX
|
Jula Inrig
CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct | 4,207 Reduced 4.7% |
$84,644
$20.12 p/Share
|
Feb 03
2025 |
|
TVTX
|
Eric M Dube
CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct | 50,691 Reduced 10.53% |
$1,024,465
$20.21 p/Share
|
Feb 03
2025 |
|
TVTX
|
Elizabeth E Reed
SVP, GC & CORPORATE SECRETARY |
SELL
Open market or private sale
|
Direct | 8,951 Reduced 9.09% |
$177,050
$19.78 p/Share
|
Feb 03
2025 |
|
TVTX
|
William E. Rote
SENIOR VICE PRESIDENT, R&D |
SELL
Open market or private sale
|
Direct | 8,951 Reduced 8.55% |
$177,050
$19.78 p/Share
|
Feb 03
2025 |
|
EA
|
Vijayanthimala Singh
Chief People Officer |
SELL
Open market or private sale
|
Indirect | 1,000 Reduced 0.0% |
$122,030
$122.03 p/Share
|
Feb 03
2025 |
|
NFLX
|
Ann Mather
Director |
SELL
Open market or private sale
|
Direct | 2,682 Reduced 100.0% |
$2,609,586
$973.0 p/Share
|
Feb 03
2025 |
|
TRU
|
Steven M Chaouki
President, US Markets |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 1.68% |
$95,950
$95.95 p/Share
|
Feb 03
2025 |
|
NFLX
|
Reed Hastings
Executive Chairman |
SELL
Open market or private sale
|
Direct | 32,067 Reduced 98.92% |
$31,313,104
$976.49 p/Share
|
Feb 03
2025 |
|
GWRE
|
Michael George Rosenbaum
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 1,400 Reduced 0.5% |
$291,788
$208.42 p/Share
|
Feb 03
2025 |
|
GWRE
|
John P Mullen
President |
SELL
Open market or private sale
|
Direct | 3,000 Reduced 1.69% |
$627,630
$209.21 p/Share
|
Feb 03
2025 |
|
ARQT
|
Larry Todd Edwards
Officer |
SELL
Open market or private sale
|
Direct | 2,173 Reduced 1.58% |
$27,597
$12.7 p/Share
|
Feb 03
2025 |
|
ARQT
|
Patrick Burnett
Officer |
SELL
Open market or private sale
|
Direct | 12,116 Reduced 9.54% |
$153,873
$12.7 p/Share
|
Feb 03
2025 |
|
ARQT
|
Howard G. Welgus
Director |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 6.58% |
$127,100
$12.71 p/Share
|
Feb 03
2025 |
|
ARQT
|
Todd Franklin Watanabe
Director |
SELL
Open market or private sale
|
Direct | 19,301 Reduced 2.34% |
$245,122
$12.7 p/Share
|
Feb 03
2025 |
|
ARQT
|
Masaru Matsuda
Officer |
SELL
Open market or private sale
|
Direct | 8,338 Reduced 4.46% |
$105,892
$12.7 p/Share
|
Feb 03
2025 |
|
RSI
|
Mattias Stetz
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 25,000 Reduced 4.27% |
$360,000
$14.4 p/Share
|
Feb 03
2025 |
|
RSI
|
Einar Roosileht
Chief Information Officer |
SELL
Open market or private sale
|
Direct | 70,000 Reduced 6.89% |
$1,008,700
$14.41 p/Share
|
Feb 03
2025 |
|
SMC
|
J Heath Deneke
Chairman, President and CEO |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 0.38% |
$41,040
$41.04 p/Share
|
Feb 03
2025 |
|
PCVX
|
Jim Wassil
CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct | 8,000 Reduced 3.74% |
$694,960
$86.87 p/Share
|
Feb 03
2025 |
|
BSX
|
Arthur C Butcher
EVP& Grp Pres, MedSurg & APAC |
SELL
Open market or private sale
|
Direct | 17,313 Reduced 75.88% |
$1,762,290
$101.79 p/Share
|
Feb 03
2025 |
|
ATEC
|
David Sponsel
EVP, SALES |
SELL
Open market or private sale
|
Direct | 36,256 Reduced 4.7% |
$414,043
$11.42 p/Share
|
Feb 03
2025 |
|
SEMR
|
Eugenie Levin
President |
SELL
Open market or private sale
|
Direct | 15,093 Reduced 2.97% |
$258,241
$17.11 p/Share
|
Feb 03
2025 |
|
SNOW
|
Christopher William Degnan
Chief Revenue Officer |
SELL
Open market or private sale
|
Direct | 12,782 Reduced 3.98% |
$2,306,000
$180.41 p/Share
|
Feb 03
2025 |
|
AI
|
Richard C Levin |
SELL
Open market or private sale
|
Direct | 12,000 Reduced 6.91% |
$358,080
$29.84 p/Share
|
Feb 03
2025 |